Wistar-Penn Collaboration Identifies HSP70 as Promising New Target for Melanoma Therapy
March 12th 2015A 10-year collaboration between scientists at The Wistar Institute and the University of Pennsylvania has recently resulted in the emergence of an exciting new target for cancer therapy, heat shock protein 70, that could be helpful in treating patients with melanoma.
Read More